Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMRN BioMarin Pharmaceutical	$56.19 +2.2%	$58.21	$52.93 ▼ $94.85	$10.54B	0.17	1.71 million shs	2.84 million shs
GEHC GE HealthCare Technologies	$75.95 +2.5%	$71.16	$57.65 ▼ $94.80	$33.92B	1.14	3.50 million shs	3.26 million shs
HOLX Hologic	$65.33 +0.3%	$60.31	$51.90 ▼ $84.67	$14.52B	0.55	2.37 million shs	2.17 million shs
PHG Koninklijke Philips	$24.20 +0.9%	$23.73	$20.61 ▼ $31.57	$23.09B	0.76	893,723 shs	802,017 shs

20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMRN BioMarin Pharmaceutical	+2.22%	+2.74%	-3.10%	-17.75%	-31.58%
GEHC GE HealthCare Technologies	+2.54%	+5.52%	+8.56%	-4.30%	-0.41%
HOLX Hologic	+0.26%	+0.77%	+5.20%	+7.88%	-11.84%
PHG Koninklijke Philips	+0.88%	+1.25%	+5.03%	-2.69%	-3.51%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BMRN BioMarin Pharmaceutical	4.9559 of 5 stars	3.4	3.0	0.0	3.3	3.3	2.5	4.4
GEHC GE HealthCare Technologies	4.1923 of 5 stars	3.4	3.0	1.7	0.0	3.5	1.7	2.5
HOLX Hologic	4.7278 of 5 stars	3.2	4.0	0.0	4.3	3.1	3.3	1.3
PHG Koninklijke Philips	3.768 of 5 stars	0.0	5.0	1.7	0.0	3.1	0.0	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BMRN BioMarin Pharmaceutical	2.74	Moderate Buy	$93.45	66.32% Upside
GEHC GE HealthCare Technologies	2.83	Moderate Buy	$88.27	16.22% Upside
HOLX Hologic	2.41	Hold	$77.42	18.50% Upside
PHG Koninklijke Philips	3.00	Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest HOLX, PHG, GEHC, and BMRN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/27/2025	HOLX Hologic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
5/13/2025	HOLX Hologic	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$77.00 ➝ $70.00
5/6/2025	GEHC GE HealthCare Technologies	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$86.00 ➝ $78.00
5/5/2025	BMRN BioMarin Pharmaceutical	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$124.00 ➝ $104.00
5/5/2025	GEHC GE HealthCare Technologies	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral	$74.00 ➝ $73.00
5/5/2025	HOLX Hologic	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$77.00 ➝ $65.00
5/2/2025	BMRN BioMarin Pharmaceutical	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$82.00 ➝ $78.00
5/2/2025	HOLX Hologic	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$75.00 ➝ $70.00
5/2/2025	HOLX Hologic	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$90.00 ➝ $71.00
5/2/2025	HOLX Hologic	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$65.00 ➝ $62.00
5/2/2025	HOLX Hologic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BMRN BioMarin Pharmaceutical	$2.85B	3.78	$3.32 per share	16.93	$29.69 per share	1.89
GEHC GE HealthCare Technologies	$19.67B	1.77	$5.92 per share	12.82	$18.53 per share	4.10
HOLX Hologic	$4.03B	3.61	$5.51 per share	11.85	$22.09 per share	2.96
PHG Koninklijke Philips	$19.50B	1.19	$3.13 per share	7.74	$13.86 per share	1.75

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BMRN BioMarin Pharmaceutical	$426.86M	$2.69	20.89	12.89	0.75	17.76%	11.34%	8.95%	8/4/2025 (Estimated)
GEHC GE HealthCare Technologies	$1.99B	$4.75	15.99	14.61	2.50	11.02%	24.95%	6.38%	7/30/2025 (Estimated)
HOLX Hologic	$789.50M	$2.37	27.57	14.14	2.39	13.83%	19.71%	10.87%	8/4/2025 (Estimated)
PHG Koninklijke Philips	-$758.55M	$0.43	56.28	12.54	0.68	2.11%	10.97%	4.57%	7/29/2025 (Estimated)

Latest HOLX, PHG, GEHC, and BMRN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	GEHC GE HealthCare Technologies	$0.91	N/A	N/A	N/A	$4.96 billion	N/A
7/29/2025	Q2 2025	PHG Koninklijke Philips	$0.2907	N/A	N/A	N/A	$4.35 billion	N/A
5/6/2025	Q1 2025	PHG Koninklijke Philips	$0.14	$0.27	+$0.13	$0.09	$4.10 billion	$4.31 billion
5/1/2025	Q2 2025	HOLX Hologic	$1.02	$1.03	+$0.01	-$0.08	$1.00 billion	$1.01 billion
4/30/2025	Q1 2025	GEHC GE HealthCare Technologies	$0.91	$1.01	+$0.10	$1.23	$4.66 billion	$4.78 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BMRN BioMarin Pharmaceutical	N/A	N/A	N/A	N/A	N/A
GEHC GE HealthCare Technologies	$0.14	0.18%	N/A	2.95%	1 Years
HOLX Hologic	N/A	N/A	N/A	N/A	N/A
PHG Koninklijke Philips	$0.82	3.39%	N/A	190.70%	N/A

Latest HOLX, PHG, GEHC, and BMRN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/1/2025	GEHC GE HealthCare Technologies	quarterly	$0.0350	0.19%		7/25/2025	8/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BMRN BioMarin Pharmaceutical	0.10	5.52	3.49
GEHC GE HealthCare Technologies	0.73	0.98	0.76
HOLX Hologic	0.54	3.24	2.52
PHG Koninklijke Philips	0.60	1.28	0.79

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BMRN BioMarin Pharmaceutical	98.71%
GEHC GE HealthCare Technologies	82.06%
HOLX Hologic	94.73%
PHG Koninklijke Philips	13.67%

Insider Ownership

Company	Insider Ownership
BMRN BioMarin Pharmaceutical	0.85%
GEHC GE HealthCare Technologies	0.27%
HOLX Hologic	1.88%
PHG Koninklijke Philips	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BMRN BioMarin Pharmaceutical	3,040	191.78 million	190.15 million	Optionable
GEHC GE HealthCare Technologies	53,000	457.89 million	456.65 million	Optionable
HOLX Hologic	7,063	222.85 million	218.66 million	Optionable
PHG Koninklijke Philips	66,678	962.92 million	N/A	Optionable

HOLX, PHG, GEHC, and BMRN Headlines

Recent News About These Companies

Philips, Medtronic re-up patient monitoring partnership

July 1 at 6:27 PM | fiercebiotech.comF

Koninklijke Philips N.V. (NYSE:PHG) Shares Sold by Envestnet Portfolio Solutions Inc.

July 1 at 3:36 AM | marketbeat.com

EOFY Sale 2025: Save $251 on Philips 5000 Series XXL Air Fryer

June 30 at 6:49 PM | news.com.auN

Philips, Medtronic expand patient monitoring collaboration

June 30 at 6:49 PM | massdevice.com

PHG Koninklijke Philips N.V. - Seeking Alpha

June 27, 2025 | seekingalpha.com

Perpetual Ltd Has $21.61 Million Holdings in Koninklijke Philips N.V. (NYSE:PHG)

June 27, 2025 | marketbeat.com

Philips Hue Prices Set to Rise Beginning July 1 Due to Impending Tariffs

June 26, 2025 | techtimes.comT

Philips Hue lighting is getting even more expensive on July 1 as a ‘direct result’ of tariffs

June 26, 2025 | 9to5google.com9

Philips Hue smart lights are already pricey. They’re about to get pricier

June 26, 2025 | msn.com

Philips Evnia 27M2N3501PA Review: Affordable QHD 240Hz Gaming Monitor

June 26, 2025 | guru3d.comG

You've got one week to stock up on Philips Hue gear before a tariff-fueled price hike

June 26, 2025 | androidauthority.comA

Philips Hue says US prices will go up in July because of tariffs

June 26, 2025 | msn.com

Philips Hue bulbs will be even more expensive in July. And it may not end there.

June 26, 2025 | arstechnica.comA

Global Assets Advisory LLC Acquires New Shares in Koninklijke Philips N.V. (NYSE:PHG)

June 26, 2025 | marketbeat.com

Methodist Hospitals Selects Philips to Advance Neurovascular, Cardiology and Complex Interventional Radiology Services in Northwest Indiana

June 25, 2025 | businesswire.com

Philips’ Dr Carla Goulart Peron on AI, equity and the future of care

June 25, 2025 | emjreviews.comE

Aurora Private Wealth Inc. Buys New Shares in Koninklijke Philips N.V. (NYSE:PHG)

June 25, 2025 | marketbeat.com

PHG - Koninklijke Philips NV ADR Dividends - Morningstar

June 24, 2025 | morningstar.comM

QRG Capital Management Inc. Has $3.62 Million Stock Position in Koninklijke Philips N.V. (NYSE:PHG)

June 19, 2025 | marketbeat.com

Philips’ new ambient wall light is now available

June 18, 2025 | msn.com

Philips launches Hair Dryer 8000, aims to preserve hair strength and moisture

June 18, 2025 | cnbctv18.comC

New MarketBeat Followers Over Time

Media Sentiment Over Time

HOLX, PHG, GEHC, and BMRN Company Descriptions

BioMarin Pharmaceutical NASDAQ:BMRN

$56.19 +1.22 (+2.22%)

Closing price 07/1/2025 04:00 PM Eastern

Extended Trading

$56.50 +0.31 (+0.55%)

As of 08:00 AM Eastern

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California.

GE HealthCare Technologies NASDAQ:GEHC

$75.95 +1.88 (+2.54%)

Closing price 07/1/2025 04:00 PM Eastern

Extended Trading

$76.26 +0.31 (+0.41%)

As of 08:00 AM Eastern

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Hologic NASDAQ:HOLX

$65.33 +0.17 (+0.26%)

Closing price 07/1/2025 04:00 PM Eastern

Extended Trading

$65.33 0.00 (0.00%)

As of 07/1/2025 05:05 PM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Koninklijke Philips NYSE:PHG

$24.20 +0.22 (+0.92%)

Closing price 07/1/2025 03:59 PM Eastern

Extended Trading

$24.28 +0.07 (+0.31%)

As of 08:00 AM Eastern

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time